Wang Qingtao, Chen Yuhai, Gao Shijuan, Jiang Wei, Song Liping, Huang Wenlin
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Sheng Wu Gong Cheng Xue Bao. 2011 May;27(5):773-80.
New strategies to improve vaccine efficacy against human immunodeficiency virus type 1 (HIV-1) are still required. DNA vaccines, exhibiting potential advantages over conventional vaccines for their simplicity and versatility, can induce specific humoral and cellular immune responses. We developed a recombinant pVAX1 DNA vector carrying p24 gene of HIV-1. The results showed that pVAX1 mediated gene possessed the ability of effective expression in both transfected 293T cells and BALB/c mice. And pVAX1-p24 DNA prime and boost immunization can induce significant P24-specific humoral immune responses and cellular immune responses in BALB/c mice. Furthermore, immunization with pVAX1-p24 DNA prime and protein boost induced 7.3 to 8.0-fold greater p24-specific humoral responses than pVAX1-p24 DNA prime and boost, while the cellular immune responses induced by combined immunization was lower. The results suggested that pVAX1-p24 DNA and P24 protein vaccine is a promising HIV-1 vaccine, and the selections of the immunization strategies are important for the immunization results.
仍需要改进针对1型人类免疫缺陷病毒(HIV-1)疫苗效力的新策略。DNA疫苗相较于传统疫苗具有简单性和多功能性等潜在优势,能够诱导特异性体液免疫和细胞免疫反应。我们构建了一种携带HIV-1 p24基因的重组pVAX1 DNA载体。结果表明,pVAX1介导的基因在转染的293T细胞和BALB/c小鼠中均具有有效表达的能力。并且pVAX1-p24 DNA初免和加强免疫可在BALB/c小鼠中诱导显著的P24特异性体液免疫反应和细胞免疫反应。此外,pVAX1-p24 DNA初免和蛋白加强免疫诱导的p24特异性体液反应比pVAX1-p24 DNA初免和加强免疫高7.3至8.0倍,而联合免疫诱导的细胞免疫反应较低。结果提示,pVAX1-p24 DNA和P24蛋白疫苗是一种有前景的HIV-1疫苗,免疫策略的选择对免疫效果很重要。